Predicting optimal interventions for clinical depression: Moderators of outcomes in a positive psychological intervention vs. cognitive-behavioral therapy.


Journal

General hospital psychiatry
ISSN: 1873-7714
Titre abrégé: Gen Hosp Psychiatry
Pays: United States
ID NLM: 7905527

Informations de publication

Date de publication:
Historique:
received: 12 02 2019
revised: 02 07 2019
accepted: 08 07 2019
pubmed: 10 8 2019
medline: 21 5 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

Identifying differences in the clinical response to specific interventions is an important challenge in the field of Clinical Psychology. This is especially true in the treatment of depression where many treatments appear to have comparable outcomes. In a controlled trial, we compared a positive psychology group intervention, the Integrative Positive Psychological Intervention for Depression (IPPI-D; n = 62) to a cognitive-behavioral therapy group intervention (CBT; n = 66) for depression. No statistically or clinically-significant differences between the treatments were found, but a slight advantage was observed, on average, for IPPI-D. The aim of the present study was to identify and combine moderators of the differential efficacy of these two psychological interventions for clinical depression. For this purpose, a secondary analysis using the Personalized Advantage Index (PAI) was performed to identify the intervention predicted to produce the better outcome for each patient. Six of the 21 potential moderators were found to predict differential efficacy between the treatments. IPPI-D was predicted to be the optimal treatment for 73% of the sample. Baseline features that characterized these individuals were: mental and physical comorbidity, prior antidepressant medication, higher levels of negative thoughts, and higher personal growth. The 27% who were predicted to achieve better outcomes in CBT than in IPPI-D tended to have these baseline features: no comorbidities, no prior antidepressant medication, lower levels of negative thoughts, and lower personal growth.

Identifiants

pubmed: 31395363
pii: S0163-8343(19)30053-2
doi: 10.1016/j.genhosppsych.2019.07.004
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-110

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Irene Lopez-Gomez (I)

School of Health Sciences, Rey Juan Carlos University, Madrid, Spain. Electronic address: irene.lopez.gomez@urjc.es.

Lorenzo Lorenzo-Luaces (L)

Department of Psychological and Brain Sciences, College of Arts & Sciences, Indiana University Bloomington, United States of America. Electronic address: lolorenz@indiana.edu.

Covadonga Chaves (C)

Department of Psychology, Faculty of Health Sciences, Francisco de Vitoria University, Madrid, Spain. Electronic address: cchavesv@psi.ucm.es.

Gonzalo Hervas (G)

Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, Spain. Electronic address: ghervas@psi.ucm.es.

Robert J DeRubeis (RJ)

Department of Psychology, University of Pennsylvania, Philadelphia, United States of America. Electronic address: derubeis@psych.upenn.edu.

Carmelo Vazquez (C)

Department of Clinical Psychology, School of Psychology, Complutense University of Madrid, Spain. Electronic address: cvazquez@psi.ucm.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH